Everolimus induced pulmonary thromboembolism after kidney transplantation; a case report
Choice of maintenance immunosuppressive therapy after renal transplantation is important for graft survival. However, complication may also occur. Venous thromboembolic event with the mTOR inhibitor (mTORi) everolimus is a rare but life-threatening complication. Here we describe a renal transplant r...
Saved in:
Main Authors: | Fereshteh Saddadi (Author), Mohammad Hassan Fallahkohan (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transplant renal artery stenosis without hypertension: A case report
by: Fereshteh Saddadi, et al.
Published: (2020) -
Use of everolimus following kidney transplantation during pregnancy: A case report and systematic review
by: Pony Yee-Chee Chai, et al.
Published: (2023) -
Widespread sebaceous hyperplasia on the face of a kidney transplant recipient after the initiation of everolimus treatment
by: Funda Tamer, et al.
Published: (2024) -
Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen
by: Stephan Ruben, et al.
Published: (2018) -
PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015)